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Abstract: Vascular inflammation is present in a subset of patients with
cerebral amyloid angiopathy (CAA) and has a major influence in
determining the disease manifestations. Radiological characterization
of this subset is particularly important to achieve early recognition and
treatment. We conducted this study to investigate the role of imaging in
differentiating CAA with and without inflammation. We reviewed
neuroimaging findings for 54 patients seen at Mayo Clinic over 25
years with pathological evidence of CAA and with available neuroima-
ging at the time of diagnosis. Clinical data were also recorded. Patients
were grouped into CAA alone (no vascular inflammation), Ab-related
angiitis or ABRA (angiodestructive inflammation), and CAA-related
inflammation or CAA-RI (perivascular inflammation). Imaging findings
at presentation were compared among patient subgroups. Radiological
features supporting a diagnosis of ABRA or CAA-RI were identified.
Radiologic findings at diagnosis were available in 27 patients with CAA
without inflammation, 22 with ABRA, and 5 with CAA-RI. On MRI,
leptomeningeal disease alone or with infiltrative white matter was
significantly more frequent at presentation in patients with ABRA or
CAA-RI compared with those with CAA (29.6% vs. 3.7%,P¼ 0.02; and
40.7% vs. 3.7%, P¼ 0.002, respectively), whereas lobar hemorrhage
was more frequent in patients with CAA (62.3% vs. 7.4%, P¼ 0.0001).
Overall, leptomeningeal involvement at presentation was present in
70.4% of patients with ABRA or CAA-RI and in only 7.4% of patients
with CAA (P¼ 0.0001). The sensitivity and specificity of leptomenin-
geal enhancement to identify patients with ABRA or CAA-RI weres, MD, Caterina G hD,
istianson, BS, and Gene G. Hunder, MD
respectively, whereas the positive LR was 8.5. Microbleeds were found
in 70.4% of patients with inflammatory CAA at presentation. In
conclusion, leptomeningeal enhancement and lobar hemorrhage at
presentation may enable differentiation between CAA with and without
inflammation. The identification at initial MRI of diffuse cortical-
subcortical microbleeds in elderly patients presenting with infiltrative
white matter process or prominent leptomeningeal enhancement is
highly suggestive of vascular inflammatory CAA.
(Medicine 95(20):e3613)
Abbreviations: ABRA = Ab-related angiitis, CAA = cerebral
amyloid angiopathy, CAA-RI = CAA-related inflammation, CIs =
confidence intervals, CT = computed tomography, CTA = CT-
angiography, GRE = gradient-echo, LRs = likelihood ratios, MRA
= MR-angiography, MRI = magnetic resonance imaging, NPV =
negative predictive value, PPV = positive predictive value, SWI =
susceptibility-weighted imaging.
INTRODUCTION
C erebrovascular deposition of amyloid (sporadic cerebralamyloid angiopathy or CAA) is characterized by depo-
sition of amyloid-b in the media and adventitia of cortical and
leptomeningeal vessels.1–4 Vascular inflammation may also be
present in amyloid-affected vessels. Two types of inflammatory
response have been reported.1,6–8 Ab-related angiitis or ABRA
is an angiodestructive process characterized by a vasculitic
transmural, often granulomatous, inflammatory infiltration.
CAA-related inflammation (CAA-RI) is characterized by an
inflammatory reaction that surrounds amyloid-laden vessels,
without angiodestructive features. Prevalence of CAA increases
with increasing age, but often remains clinically occult. When
clinically evident, CAA most commonly presents as a lobar
intracerebral hemorrhage in an elderly normotensive patient.2,3
In patients with associated vascular inflammation, intracranial
hemorrhage is less frequent and such patients often present with
findings of subacute cognitive decline, seizures, and headaches
and respond to immunosuppressive therapy.1,6–8
CAA, CAA-RI, and ABRA all have varied neuroradio-
graphic appearances including intraparenchymal lobar hemor-
rhage, microhemorrhages centered at the gray white junction,
white matter infiltrative nonenhancing T2 hyperintense mass-
like lesions, leptomeningeal disease, or a combination of any of
the above. Few series have focused on the radiological-path-
ology correlative findings, which may guide the clinical andng process.9–14 Radiological character-
s with vascular inflammation is particu-
ieve early recognition and treatment,
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avoid nondiagnostic biopsies, improve outcomes, and minimize
the risk of unnecessary treatment with glucocorticoids and/or
cyclophosphamide. The purposes of this study were to review
our experience with imaging findings at presentation of path-
ology-proven CAA and to identify radiological features sup-
porting a diagnosis of ABRA or CAA-RI.
PATIENTS AND METHODS
Identification of the Patients
In this study, we included all patients seen at Mayo Clinic
in Rochester, MN, between January 1987 and December 2011
diagnosed on pathology specimen with CAA and had available
neuroimaging at presentation.1 All pathological specimens were
reviewed by one neuropathologist (CG) to exclude other vas-
cular pathologies, to evaluate the presence of concomitant
neurodegenerative changes of Alzheimer type, and to evaluate
the presence and distribution of inflammation associated with
amyloid-b. A detailed description of the pathologic and classi-
fication procedures including imaging categorization was
reported in previous studies.1,6,15–18 Patients were grouped into
3 groups: CAA alone (no vascular inflammation), ABRA
(angiodestructive inflammation), and CAA-RI (perivascular
inflammation without angiodestructive process).1 The review
of all available neuroimaging findings was performed by an
experienced CAQ neuroroadiologist (JMM), who had no access
to the clinical data or knowledge of the pathology report.
Imaging modalities reviewed included computed tomogra-
phy (CT), magnetic resonance imaging (MRI), CT-angiography
(CTA), MR-angiography (MRA), and catheter angiography. All
these imaging modalities were performed and interpreted by
defined clinical protocols used by the Division of Neuroradiol-
ogy at the Mayo Clinic.
Neuroimaging was reviewed for the location and presence
of the following findings: lobar hemorrhages, microhemor-
rhages at the gray white junction on gradient-echo (GRE) or
susceptibility-weighted imaging (SWI), associated vasogenic
edema in the underlying white matter, leptomeningeal or
pachymeningeal involvement, enhancing mass-like lesions,
cerebral infarcts, attenuation of these changes on CT, postga-
dolinium enhancement characteristics, or any combination
of above.
Medical history and clinical and laboratory findings at
presentation and during the follow-up as well as response to
treatment, relapse occurrence, follow-up functional status, and
cause of death were recorded.
Standard Protocol Approvals, Registrations, and
Patients Consents
The Mayo Institutional Review Board approved this study.
The IRB number was 11–003530.
Statistical Analysis
Numeric parameters were compared by using a 2-sided 2-
sample t test or a Wilcoxon rank-sum test when the distri-
butions were skewed. Comparisons of categorical variables
were performed using the x2 or Fischer exact test when cell
counts were <5. We determined sensitivities (% of patients
with a disease who have a positive test), specificities (% of
patients without the condition who have a negative test),
Salvarani et alpredictive values (positive predictive value [PPV]¼ number
of true positives/number of true positivesþ number of false
positives, negative predictive value [NPV]¼ number of true
2 | www.md-journal.comnegatives/number of true negativesþ number of false nega-
tives), and likelihood ratios (LRs) (LRþ¼ sensitivity/1-speci-
ficity, LR¼ 1sensitivity/specificity) with 95% confidence
intervals (CIs).19 Significance was defined at P< 0.05. The
statistical analysis was performed using SAS version 8 (SAS
Institute, Cary, NC).
RESULTS
Seventy-eight consecutive patients with cerebral vascular
Ab deposition were identified.1 Neuroimaging findings at pres-
entation were available for review in 54 cases (27 CAA, 22
ABRA, and 5 CAA-RI), who represent the study population. Ten
cases were evaluated with CT alone (ABRA¼ 1, CAA¼ 9), 16
caseswere evaluatedwithMRI alone (ABRA¼ 11, CAA-RI¼ 3,
CAA¼ 2), and 28 cases were evaluated with CT and MRI
(ABRA¼ 10, CAA-RI¼ 2, CAA¼ 16). CTA, MRA, and con-
ventional angiography were additionally performed in 21 cases
(ABRA¼ 6, CAA-RI¼ 3, CAA¼ 12). No angiographic evi-
dence of vasculitis (smooth-wall segmental narrowing, dilatation,
or occlusion affecting multiple cerebral arteries)15 was observed
in the 3 groups of patients. Twenty-nine cases had either aGREor
SWI sequence performed.
Location of Imaging Abnormalities
In 18 cases, imaging abnormalities involved 1 lobe
(ABRA¼ 3, CAA¼ 15). One case of CAA involved a cerebel-
lar hemisphere. In 35 cases, abnormalities were multilobar
(ABRA¼ 19, CAA-RI¼ 5, CAA¼ 11). Twenty-five cases
were bilateral (ABRA¼ 14, CAA-RI¼ 3, CAA¼ 8). Patients
with ABRA and CAA-RI had a significantly higher frequency
of multilobar abnormalities compared to those with CAA
(62.9% vs. 29.6%, P¼ 0.028). The frontal lobe was the most
frequently involved (ABRA¼ 22, CAA-RI¼ 3, CAA¼ 16).
Enhancement
Twenty-three cases demonstrated some form of postcon-
trast enhancement. Twenty-one cases had leptomeningeal
enhancement (ABRA¼ 15, CAA-RI¼ 4, CAA¼ 2), and 2
cases of CAA had mass-like enhancement.
Vasogenic Edema/Mass Effect/Previous
hemorrhage
Thirty-nine cases showed evidence of vasogenic edema
(ABRA¼ 16, CAA-RI¼ 4, CAA¼ 23). The mass effect from
lobar hemorrhage resulted in hydrocephalus or herniation
respectively in 5 and 6 cases of CAA. Evidence of previous
microhemorrhage (foci of hemosiderin) was seen in 29 cases by
utilization of GRE and/or SWI sequences (ABRA¼ 15, CAA-
RI¼ 4, CAA¼ 10). Table 1 shows these radiological findings
at presentation.
CAA radiological Findings at Presentation and
During Follow-Up
Lobar hemorrhage was the most frequent presentation,
occurring in 17 of 27 (63%) of those with CAA. A single lobar
hemorrhage was present in 15, whereas 2 other patients had
multiple intraparenchymal hemorrhages of different ages. A
leptomeningeal process was the only MRI finding in 1 patient
(3.7%). Another had a leptomeningeal process with associated
Medicine  Volume 95, Number 20, May 2016vasogenic edema underlying this region (3.7%). An infiltrative
white matter process mimicking a low-grade glioma was pre-
sent in 4 others (14.8%) (Figure 1). Four patients had other
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Radiological (MRI and/or CT) Findings at Presentation
Imaging Presentations n¼ 54 ABRA (n¼ 22), A CAA-RI (n¼ 5), B CAA (n¼ 27), C P (AþB vs. C)
Lobar hemorrhage 19 2 0 17 0.0001
Isolated 0 0 15
With multiple intraparenchymal
hemorrhages of different ages
0 0 2
Strictly leptomeningeal process 9 6 2 1 0.02
Isolated 4 1 1
With multiple cortical infarcts 1 0 0
With multiple intraparenchymal
hemorrhages of different ages
1 0 0
With old lobar infarct 0 1 0
Leptomeningeal process with
infiltrative white matter
12 9 2 1 0.002
Isolated 8 2 1
With multiple cortical infarcts 1 0 0
Infiltrative white matter process
mimicking low grade glioma
8 4 0 4 1.0000
Isolated 3 0 3
With multiple old lobar infarcts 1 0 0
With multiple intraparenchymal
hemorrhages of different ages
0 0 1
Other presentations 6 1 1 4
Multiple cortical infarcts 1 0 0
Multiple acute hemorrhages 0 1 0
Mass lesion 0 0 2
Focal SAH 0 0 1
Multiple cortical infarcts and
intraparenchymal hemorrhages
of different ages
0 0 1
ABRA¼Ab-related angiitis, CAA¼ cerebral amyloid angiopathy, CAA-RI¼ cerebral amyloid angiopathy-related inflammation
SAH¼ subarachnoid hemorrhage.
FIGURE 1. Magnetic resonance imaging of a patient with CAA showing an infiltrative white matter process mimicking low grade
infiltrating glioma. A, Fluid Attenuation Inversion Recovery (FLAIR) MRI images show a T2 hyperintense infiltrative white matter process in
the left temporal/parietal lobes with associated mass effect; mild contralateral infiltrative T2 hyperintensity is also present. There was no
associated enhancement. B, Axial susceptibility weighted imaging (SWI) shows multiple bilateral microhemorrhages centered at the grey
white junction in both cerebral hemispheres, particularly evident in the area of mass-like T2 hyperintensity.
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findings at presentation: 2 had a mass-like lesion, 1 subarach-
noid hemorrhage, and 1 multiple cortical infarctions and intra-
parenchymal hemorrhages of different ages. Three patients had
multiple modalities of presentation. Follow-up images were
available in 3 patients with CAA. All 3 patients had 1 relapse.
Two relapses were characterized by the presence of a lepto-
meningeal process with infiltrative white matter, occurring 9
months and 8 years, respectively, after the initial diagnosis. The
third patient had a lobar hemorrhage 2 years after the first
episode characterized by a multilobar infiltrative white matter
process mimicking low-grade glioma.
Illustrative Cases of CAA
Case 1
A 62-year-old woman presented with recurrent multi-
focal bilateral paraesthesias. Brain MRI showed a leptome-
ningeal process and infiltrative white matter abnormalities in
right parietal lobe. Cerebral biopsy showed CAA with invol-
vement of leptomeningeal and superficial cortical vessels.
The patient was not treated and 4 months later at MRI, there
was an almost complete resolution of the lesions. Five months
later, she developed aphasia with MRI evidence of a recurrent
leptomeningeal process with infiltrative white matter abnor-
malites in the left temporal lobe. She was treated with only
three 1 g/pulses of methylprednisolone (oral glucocorticoids
did not follow pulse therapy) with significant improvement of
the language (80% of normal) in the following 10 days. Seven
months later, brain MRI had markedly improved showing only
few tiny foci of hemosiderin on GRE and language
was normal.
Case 2
A 61-year-old woman presented with a right frontal lobar
hemorrhage. Medical history was negative. Brain biopsy per-
formed during hematoma evacuation showed CAA. Eight years
later, she developed seizures and brain MRI showed infiltrative
T2 signal in the white matter with leptomeningeal enhancement
Salvarani et alin the right temporal lobe which spontaneously resolved. Three
years later, microhemorrhages were observed on follow-up
brain MRI.
FIGURE 2. Magnetic resonance imaging of a patient with ABRA showin
Recovery (FLAIR) sequence shows non nulling of the subarachnoid signa
process. No underlying white matter abnormalities. B, Post Gadolinium
C, Axial susceptibility weighted imaging (SWI) shows multiple bilat
hemispheres.
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A 47-year-old man developed progressive cognitive
decline, personality change, confusion, spells, and right hemi-
paresis. Brain MRI showed an infiltrative white matter process
mimicking low-grade glioma in the parietal lobe bilaterally and
in the right frontal lobe; in addition, there were multiple
intraparenchymal hemorrhages of different ages. A brain biopsy
showed CAA. His neurological condition and brain MRI gradu-
ally improved without therapy. Two years later, his neurologic
status suddenly deteriorated and brain MRI showed a new right
frontal lobe hemorrhage.
ABRA Radiological Findings at Presentation and
During Follow-Up
Leptomeningeal disease only (Figure 2) and with infiltra-
tive white matter abnormalities (Figure 3) were the 2 most
frequent radiological findings at presentation and were
observed in 6 (27.3%) and 9 (40.9%) of the 22 patients
respectively, followed by an infiltrative white matter process
mimicking low-grade glioma alone in 4 patients (18.2%)
(Table 1). Multiple cortical infarcts were present in 3 patients
(14%). In 1 patient, infarcts were the only finding at presen-
tation, whereas in the other 2, additional lesions developed.
Multiple old lobar infarcts were observed in another patient
associated with an infiltrative white matter process mimicking
low-grade glioma. Lobar hemorrhage was observed in only
2 patients.
Follow-up images were available in 4 patients with ABRA.
Three of the 4 had clinical relapses. One patient had 3 relapses,
one had 2, and 1 had 1 relapse. A new lobar hemorrhage was
observed in all 3 relapses. Lobar hemorrhage was associated
with subdural and subarachnoid hemorrhage in 1, recurrence of
leptomenigeal enhancement in 1, and leptomeningeal process
with infiltrative white matter process in 1.
Illustrative Cases of ABRA
Case 1
Medicine  Volume 95, Number 20, May 2016A 69-year-old woman presented with a 3-week history of
spells of numbness moving up her left arm and in her left leg to
the knee. The episodes lasted about 15 minutes, and as a second
g a strictly leptomeningeal process. A, Fluid Attenuation Inversion
l involving the left temporal lobe consistent with a leptomeningeal
T1-weighted images shows avid leptomeningeal enhancement.
eral cortical-subcortical microhemorrhages throughout cerebral
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 3. Magnetic resonance imaging of a patient with ABRA showing a leptomeningeal process with infiltrative white matter
abnormalities as well. Without GRE or SWI imaging, this can be mistaken for an infiltrative low grade glioma. A, Fluid Attenuation Inversion
e su
pto
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showed leptomeningeal enhancement in frontal and parietal
lobes. Two months later, her neurological status deteriorated
and a follow-up MRI showed a right frontal lobar hemorrhage.
Brain biopsy showed necrotizing vasculitis and CAA. Predni-
sone 60mg daily was started and she improved. Two months
later, MRI showed improvement of leptomeningeal enhance-
ment, but also revealed a new small hemorrhage in the left
posterior temporal lobe. Mycophenolate mofetil was started and
she improved further. Eight months later, the follow-up MRI
showed a complete resolution of leptomeningeal enhancement.
Medications were then discontinued. However, during sub-
sequent follow-up, the patient had 3 clinical recurrences, 12
months, 29 months, and 35 months later. In the first, recurrence
MRI showed a new left temporal lobe lobar hemorrhage, in the
second, recurrence of leptomeningeal enhancement, and in the
third, a right frontal lobar hemorrhage with subdural and
subarachnoid hemorrhage.
Case 2
A 65-year-old man developed a right frontal hemorrhage
that was evacuated. One month later, he noted headache,
confusion, seizures, aphasia, and rapid cognitive decline. Brain
MRI showed leptomeningeal enhancement involving the right
frontal and temporal lobes and multiple infarcts in the over-
lying cortex. Cerebral biopsy showed ABRA. The patients
were treated with methylprednisolone pulse therapy (1 g/day
for 3 days) followed by oral prednisone 60mg/daily. The
patient radiographically and clinically improved, and 18
months later, he was able to stop prednisone without
recurrence.
Recovery (FLAIR)-weighted MRI images show multilobar infiltrativ
effect. B, Post Gadolinium T1-weighted MRI images show avid leCase 3
A 67-year-old woman developed confusion, aphasia, and
spells, lasting 5 to 10 minutes, with numbness in her arm and
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.trunk. On several occasions, her face was drooped on the left
and her speech was slurred. MRI showed leptomeningeal
enhancement with T2 signal hyperintensity involving cortex
and adjacent white matter in the right frontal lobe and left
parietal and frontal lobes. Brain biopsy showed ABRA. The
patient was not treated and there was a progressive resolution of
neurological manifestations and MRI findings. Seven months
later, the patient was asymptomatic and follow-up MRI demon-
strated minimal persisting leptomeningeal enhancement in the
left parietal area and a marked reduction in the amount of T2
signal changes. Five years later, the patient had a recurrence
characterized by spells of aphasia and MRI evidence of lepto-
meningeal enhancement and T2 signal hyperintensity in sub-
cortical white matter with extension to the cortex in the right
occipital and temporal lobes. The neurological symptoms
resolved in the following month without therapy and a control
MRI, 5 months later, showed resolution of leptomeningeal
enhancement and marked reduction of white matter T2 abnorm-
alities. SWIs showed a few punctate areas of hemosiderin
deposition in the same regions where there were T2 abnorm-
alities. Three years later, the patient was asymptomatic and
brain MRI unchanged.
Case 4
A 62-year-old woman presented with a 2-month history of
episodes of paresthesias marching up the left arm from the
fingers to the left side of the neck and face. MRI showed right
temporal and bilateral frontal leptomeningeal enhancement and
an old right frontal hemorrhage. The patient was not treated and
the spells and MRI leptomeningeal enhancement improved
spontaneously. Five months later, she complained of headache
and MRI showed a new left posterior frontal hemorrhage and 2
bcortical white matter T2 hyperintensities, with associated mass
meningeal enhancement without parenchymal enhancement.months later, brain MRI showed a new left anterior frontal
hemorrhage. Brain biopsy was performed with evidence
of ABRA.
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CAA-RI Radiological Findings at Presentation and
During Follow-Up
Only 5 patients were in this group. Isolated leptomeningeal
enhancement or a leptomeningeal process with infiltrative white
matter was observed in 4 of 5 patients (80%). No patients had a
lobar hemorrhage. One patient presented with multiple acute
hemorrhages alone. One patient with leptomeningeal disease
alone also had evidence of an old frontal infarct. Thus, the group
appeared to resemble ABRA more than CAA.
Comparisons Between CAA and ABRARCAA-RI
Leptomeningeal disease alone or with an infiltrative under-
lying white matter process was significantly more frequent in
patients with ABRA and CAA-RI compared with those with
CAA (8/27, 29.6% vs. 1/27, 3.7%, P¼ 0.02; and 11/27, 40.7%
vs. 1/27, 3.7%, P¼ 0.002, respectively), whereas lobar hemor-
rhage was more frequent in patients with CAA (17/27, 62.3%
vs. 2/27, 7.4%, P¼ 0.0001) (Table 1). Overall, leptomeningeal
involvement at presentation was present in 70.4% (19/27) of
patients with ABRA or CAA-RI and in only 7.4% (2/27) of
patients with CAA (P¼ 0.0001). Table 2 shows the sensi-
tivities, specificities, and LRs (with 95% CIs) of imaging
findings that help differentiate patients with CAA from those
with ABRAþCAA-RI. The sensitivity and specificity of lep-
tomeningeal enhancement to identify patients with
ABRAþCAA-RI were 70.4% and 92.6%, respectively,
whereas the positive LR was 9.5. The positive predictive value
was 90.4%. The sensitivity and specificity of intracerebral
hemorrhage to identify patients with CAA were 62.9% and
92.6%, respectively, whereas the positive LR was 8.5. The
positive predictive value was 89.4%.
DISCUSSION
The primary objective of this study was to assess imaging
findings at diagnosis in a population of 54 patients with ABRA
and CAA-RI or CAA. We found that leptomeningeal disease by
itself or accompanied by infiltrative white matter process was
significantly more frequent in patients with ABRA and CAA-RI
than those with CAA, whereas lobar hemorrhage was more
frequent in patients with CAA. Overall, leptomeningeal invol-
vement at presentation was observed in 70% of the patients with
vascular inflammation, but in only 7% with CAA. In addition to
the sensitivity of 70%, MRI evidence of leptomeningeal
Salvarani et alenhancement had a specificity of 93% for the presence of
vascular inflammation. The positive LR for this MRI finding
was 9.5, indicating that leptomeningeal enhancement is almost
TABLE 2. Imaging Findings for the Diagnosis of Cerebral Amyloi
Findings
Sensitivity,
n/n (%)
(95% CI)
Specificity,
n/n (%)
(95% CI)
Positive
Predictive
Value % (95% C
ABRAþCAA-RI
Leptomeningeal
enhancement
19/27 (70.4)
(49.6, 85.5)
25/27 (92.6)
(74.2, 98.7)
90.4 (68.2, 98.3
CAA
Intracerebral
hemorrhage
17/27 (62.9)
(42.5–79.9)
25/27 (92.6)
(74.2–98.7)
89.4 (65.5, 98.1
ABRA¼Ab-related angiitis, CAA¼ cerebral amyloid angiopathy, CAA-R
interval.
6 | www.md-journal.com10 times more likely to be present in a patient with ABRA or
CAA-RI inflammation than in a patient with CAA. We also
observed that patients with intracerebral hemorrhage on ima-
ging have an increased likelihood of CAA without inflam-
mation (LR, 8.5). However, the absence of intracerebral
hemorrhage decreased the probability of CAA without vascular
inflammation. The negative LR for intracerebral hemorrhage
was 0.4. The specificity of intracranial hemorrhage for CAA
without inflammation was high (93%), whereas the sensitivity
was relatively low (63%). Therefore, the presence of leptome-
ningeal enhancement in the absence of intracerebral hemor-
rhage increases the probability that a patient with CAA will
have vascular inflammation.
We observed that ABRA and CAA-RI were more closely
related to primary CNS vasculitis than to CAA without inflam-
matory infiltrates and that vascular inflammation in ABRA and
CAA-RI more than Ab deposition alone has a major influence
in determining disease manifestations.1,5,6 In particular, the
neurological manifestations of CAA with inflammatory vascu-
lar or perivascular infiltration respond to immunosuppressive
treatment. Therefore, when neurologic and neuroradiologic
findings are consistent with ABRA or CAA-RI, the physician
should consider starting an appropriate immunosuppressive
treatment also in absence of pathologic confirmation. If a biopsy
is requested, the surgeon should direct the biopsy to the
leptomeningeal and gray white junction.
Given the varied radiological presentations of these
patients, GRE and/or SWI are essential in narrowing the
differential diagnosis triaging the patients toward appropriate
therapy.9–12 CAA inflammatory variants may present as an
infiltrative, poorly marginated, diffuse lobar or multilobar T2-
hyperintense process with associated mass effect and variable
leptomeningeal enhancement mimicking CNS neoplasm or as
strictly leptomeningeal process in the absence of lobar hemor-
rhage. Standard MRI sequences are not sensitive for detecting
the microhemorrhages, which are also associated with these
inflammatory CAA forms. In cases who present with a none-
nhancing infiltrative white matter process and in which SWI or
GRE imaging is not done, it is not uncommon that only the
white matter is targeted in the biopsy resulting in a nondiag-
nostic biopsy and delayed treatment.11 The presence of
multiple, cortical-subcortical microbleeds detected by GRE
or by more sensitive sequences such as SWI is a suggestive
radiological sign of vascular amyloid.9–11 We found micro-
Medicine  Volume 95, Number 20, May 2016bleeds, using GRE and/or SWI sequences, in 19 of 27 (70.4%)
patients with inflammatory CAA at presentation. The identifi-
cation at initial MRI of diffuse cortical and subcortical
d Angiopathy With and Without Inflammation
I)
Negative
Predictive
Value % (95% CI)
Positive
Likelihood
Ratio (95% CI)
Negative
Likelihood
Ratio (95% CI)
) 75.7 (57.4–88.2) 9.5 (2.5–36.9) 0.3 (0.2–0.6)
) 71.4 (53.5–84.7) 8.5 (2.2–33.3) 0.4 (0.2–0.7)
I¼ cerebral amyloid angiopathy-related inflammation, CI¼ confidence
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
microhemorrhages in a distribution typical of CAA in elderly
patients presenting with infiltrative white matter process or
prominent leptomeningeal enhancement is highly suggestive of
vascular inflammatory CAA. These findings suggest that in the
proper setting, ABRA and CAA-RI might be neuroradiologi-
cally diagnosed potentially avoiding therapeutic delays also in
the absence of cerebral biopsy. Amyloid imaging with amyloid-
binding positron emission tomography ligands, such as Pitts-
burgh Compound B, may also be useful in detecting CAA,
although they cannot discriminate vascular from parenchymal
amyloid deposits.20
Follow-up data provided some additional information on
the course of CAA, in particular on the inflammatory lesions.
Patients with CAA may have different clinical or neuroradio-
logic manifestations at different times. The presenting mani-
festation may suggest a non-inflammatory event such as lobar
hemorrhage, but years later, an inflammatory appearance may
develop (CAA case 2). In other patients, the presenting mani-
festation suggests inflammation and the relapse are similar
(ABRA case 3) or noninflammatory (ABRA case 4). However,
recurrent inflammatory lesions in a patient tended to occur in
different cerebral lobes with a migratory pattern. In some, the
clinical and radiologic alterations had a self-limited course. This
migratory and reversible course with resolution without immu-
nosuppressive therapy was previously described in some case
reports.12,14,21 In these cases, as in some of our patients
(particularly ABRA cases 3 and 4), the clinical symptoms
and MRI findings recovered spontaneously in few months.
These observations raise questions about whether some cases
of ABRA can be observed without treatment.
Strengths of our study include the following: the relative
large number of consecutive patients with CAA defined by
uniform pathology criteria with cerebral imaging available at
diagnosis, radiologic images that were performed by a defined
clinical protocol, and reviewed for this study by a single
experienced neuroradiologist. Limitations include the relative
small number of patients with follow-up images available.
Limitations also include the retrospective nature of the study,
possible referral bias of cases, and sampling error of the biopsy
specimens because of the patchy nature of the inflammatory
response.
In conclusion, the clinician should be aware of the varied
imaging appearance of ABRA, CAA-RI, and CAA. Diffuse
lobar vasogenic edema or mass-like nonenhancing white matter
T2 hyperdensities may mimic low-grade infiltrative glioma or
gliomatosis cerebri. In these cases, SWI or GRE image aids in
determining the correct diagnosis, also in absence of cerebral
biopsy. If biopsy is obtained, it should be targeted at the
leptomeningeal or gray white junction and not only the
white matter.
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